logo-loader
OTCMKTS:PPCB

Propanc Biopharma Inc

Receive alerts
Market:
OTCMKTS
Market Cap:
$1.22 m
Price
$1.45
Change
3.57%
52 weeks high
144.40
52 weeks low
0.06

Filter by article type

Viewing results 1-12 of 12

Health

Propanc Biopharma wins US patent to better protect its lead cancer-fighting drug PRP

The patent covers composition of matter claims involving pancreatic proenzymes trypsinogen and chymotrypsinogen -- which together comprise PRP...

4 days, 3 hours ago
Health

Propanc Biopharma publishes promising study of its metastatic cancer drug in peer-reviewed medical journal

The study confirmed the effects its drug against cancer stem cells within tumors that are capable of self-renewal and often resist chemotherapy...

1 week, 6 days ago
Health

Propanc looks to history to capitalize on glimmering angle in cancer treatment

The company’s cancer treatment is based on work undertaken by John Beard, a professor of embryology at Edinburgh University nearly 100 years ago...

2 weeks, 3 days ago
Health

Propanc Biopharma moves closer to first-in-human study by quantifying ingredients for its metastatic cancer drug

This step allows Propanc to move forward in discussions with potential sites for its clinical trial, which the company expects to launch in early 2020...

2 weeks, 3 days ago
Health

Propanc Biopharma gears up to file clinical trial application for its lead anti-cancer therapy PRP

CEO James Nathanielsz says the company is planning a first-in-human study by undertaking “full scale manufacturing” of PRP for human use...

on 16/7/19
Health

Propanc poised to unlock shareholder value as it boosts its patent portfolio for cancer-fighting drugs

The biopharmaceutical company now has 65 patents either in force or pending in most major countries around the globe covering its lead drug candidate PRP...

on 28/6/19
Health

Propanc Biopharma taps longtime advisor as chief financial officer

Carlo Campiciano joins the biopharma as it enters important new phases of growth...

on 24/6/19
Health

Propanc welcomes founding member back to scientific advisory board

Ralf Brandt returns to the board after temporarily stepping down in 2018...

on 6/5/19
Health

Propanc CEO looks to harness power of pancreatic enzymes in cancer fight

The company’s thesis is that pancreatic enzymes can be used to halt the spread of cancer...

on 24/4/19